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doi:10.1016/j.ejvs.2008.12.003Summary Objective: To document outcomes after urgent carotid surgery in patients with
crescendo transient ischaemic attacks (CTIAs) and stroke-in-evolution (SIE).
Methods: A systematic review of the English-language literature using the MEDLINE and EM-
BASE databases ‘‘was undertaken from January 1984 through December 2007’’. Studies report-
ing the data after surgery for CTIAs and SIE were identified and stroke, stroke/death and
stroke/death/major cardiac event rates calculated. The studies were divided into those re-
porting on CTIAs (group I) and those reporting on SIE (group II).
Results: From the databases, 34 relevant series (915 patients) were retrieved. After excluding
those reports on CTIAs, SIE and other ‘urgent’ indications combined together and from which
separate data could not be extracted, a total of 12 series with 176 patients reporting on CTIAs
(group I) and 16 series with 114 patients reporting on SIE (group II) met the inclusion criteria.
All the identified studies were case series of low methodological quality suffering from selec-
tion bias. Peri-operative stroke, stroke/death and stroke/death/major cardiac event rates
were 6.5% (95% confidence interval (CI): 3.4e10.4), 9.0% (95% CI: 4.3e15.1) and 10.9% (95%
CI: 5.5e17.9), respectively, in group I; and 16.9% (95% CI: 9.2e26.2), 20.0% (95% CI: 12.5e
28.6) and 20.8% (95% CI: 13.2e29.6), respectively, in group II.
Conclusions: The combined risk of neurological and cardiac complications following urgent
carotid surgery for unstable neurological symptoms, such as CTIAs and SIE, is higher than that
anticipated after elective surgery for stable symptoms.
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280 C.D. Karkos et al.Although clear evidence from large European and American ‘evolving’ stroke (progression occurs over at least a 24-htrials exists that elective carotid endarterectomy (CEA) is
an effective intervention for patients with symptomatic
severe carotid stenosis,1e3 and, to a lesser extent, for
asymptomatic stenosis,3,4 there is no evidence from rand-
omised trials supporting the use of emergency or urgent
CEA in clinical practice. Nevertheless, current opinion
supports the role of urgent carotid surgery for crescendo
transient ischaemic attacks (CTIAs) and stroke-in-evolution
(SIE).5e40 Since the underlying aetiology is thought to be an
acutely unstable plaque with overlying thrombus and,
therefore, a high risk for stroke, both these phenomena are
considered to be medical emergencies, and the patient
should be admitted directly to the hospital for urgent
evaluation and treatment. To date, no reliable data are
available about the risks of CEA for CTIAs or SIE. Some
studies have reported very high operative risks,24,39
whereas others have suggested that the risk is similar to
that for stable symptoms.26,30 Moreover, it was the authors’
impression that these neurologically unstable patients are
also at higher risk for acute cardiac complications, either as
a result of systemic inflammation and/or atherosclerotic
plaque instability or because of the large burden of coro-
nary artery disease in this population.38 The purpose of this
systematic review and meta-analysis was to document the
results of urgent carotid surgery in neurologically unstable
patients presenting with CTIAs and SIE with a particular
emphasis on stroke, mortality and cardiac complications.
This article was prepared according to the previously pub-
lished guidelines for reporting meta-analyses of observa-
tional studies.41Methods
An English-language literature review was undertaken from
January 1984 through December 2007 to document the
results of urgent carotid surgery for patients presenting
with CTIAs and SIE. An electronic MEDLINE and EMBASE
database search was performed using the Ovid search
engine (Version rel. 10.5.1; Ovid Technologies, Inc., New
York, USA) and the terms: ‘urgent carotid endarterectomy’,
‘urgent carotid surgery’, ‘crescendo transient ischaemic
attack’ and ‘stroke in evolution’, alone and in combination.
Both the ‘exp’ (‘explode’, i.e., all sub-categorisations are
included in the search) and ‘mp’ (‘multipurpose search’)
tools were used. References from the relevant articles
were also searched. Review and meta-analysis articles on
the subject were also identified and scrutinised. Selection
of studies and data abstracting were performed indepen-
dently by two of the authors (CDK, IHL) and the discrep-
ancies were resolved by consensus.
CTIA has been defined as repeated TIAs within a rela-
tively short period of time. On each occasion, the neuro-
logical deficit will have fully recovered before the onset of
the next event, and these may occur on a daily basis and be
more frequent and more severe. On the other hand, SIE has
been defined as the progression of a neurological deficit
that has occurred over at least a 24-h period and can be
a ‘fluctuating’ stroke (progressive worsening of deficit over
at least a 24-h period, but within the 24-h period, deficit
waxes and wanes but never clears completely) or anperiod and there is no waxing and waning, but a gradual
increase in deficit).19
Available studies were divided into two groups: group I
included articles with data on patients presenting with
CTIAs, and group II consisted of data on SIE patients.
Stroke, stroke/death and stroke/death/major cardiac
event rates were the three primary end-points of urgent
carotid surgery used in this study. The series were included
only when details on all three primary end-points were
quoted or could be extracted. The series which reported on
CTIA or SIE mixed with other urgent indications or pre-
sented together with stable symptomatic or even asymp-
tomatic patients and from which separate information on
CTIA or SIE could not be extracted were excluded. In case
of studies reporting on duplicate clinical material, the most
recent study or the larger of the two was selected for
analysis. With regards to mortality, the 30-day and/or the
in-hospital rates are reported here depending on the
information available from each study. For the purpose of
this study, the two rates have been combined. Major
cardiac events included myocardial infarction, congestive
heart failure, unstable angina and ventricular tachyar-
rhythmias. Some studies did not clearly differentiate
between fatal and non-fatal strokes or fatal and non-fatal
cardiac events, whereas other studies gave only the
myocardial infarction rates and not all major cardiac
events. Therefore, the results and total numbers should be
interpreted with caution. Finally, not all papers reported
all the necessary information, and, hence, the denominator
may not be the same as the total number of patients in the
analysis. Assessment of methodological quality across the
included series was also performed focussing, in particular,
on potential selection or information bias and whether
multivariable corrections for co-existing diseases or case-
mix had been made. A suspicion of selection bias was
graded as ‘yes’, ‘no’ or ‘unclear’. Information bias (i.e.,
whether all end-points were properly assessed, e.g., by an
independent observer, or whether all end-points were
properly defined) was also graded as ‘yes’, ‘no’ or
‘unclear’.
The data from eligible papers were abstracted into
a Microsoft Excel spreadsheet. The results were expressed
as pooled proportions (%) with 95% confidence interval (CI).
Heterogeneity across the studies was evaluated using the
Cochran’s Q-statistic, and random effects models were
used to incorporate any heterogeneity present, as
described by Der Simonian and Laird.42 The level of signif-
icance was set at p< 0.05. Statistical analysis was per-
formed using the statistical software StatsDirect, version
2.6.2 (StatsDirect Ltd., Altricham, UK).Results
A total of 34 articles were identified in the literature as
potential sources of information on patients undergoing
carotid surgery for CTIAs and SIE.5e38 A series of 51 patients
from our own institution operated upon urgently for CTIAs
(nZ 43) and SIE (nZ 8) between January 1992 and July
2004 was also included in this analysis.38 This provided
a large amount of data on 915 patients; of whom, more
Urgent Carotid Surgery in Patients with CTIAs and SIE 281than half (58%) the numbers presented with CTIAs, 32% with
SIE and 12% with other ‘urgent’ indications, mostly acute
stroke, single TIA or a tight carotid stenosis. Thirteen
articles had been excluded as they did not meet the
inclusion criteria.5,8,10,11,13,16,20,22,28,32e34,36 These were
the studies reporting collectively on patients being oper-
ated upon for CTIA, SIE and other e the so called e ‘urgent’
indications, but failing to differentiate between the
subgroups. Separate information on the outcome of surgery
for CTIA or SIE could not be extracted, and, as a result,
these articles were excluded, thus leaving only 21 series for
analysis, 12 on CTIAs 6,7,17e19,24,26,29e31,37,38 and 16 on
SIE.6,7,9,12,14,15,19,21,23e25,27,30,31,35,38 Seven of these
provided separate data for CTIA and SIE
patients.6,7,19,24,30,31,38
CTIAs (group I)
Twelve series were identified with information on
a total of 176 patients undergoing urgent surgery for
CTIAs.6,7,17e19,24,26,29e31,37,38 Basic data, including study-
quality characteristics, are summarised in Table 1. One
study was multicentre and the remaining 10 studies were
conducted in a single centre. ‘‘All, but four,6,17,18,24
were’’ retrospective. Majority of the studies were of low
methodological quality, being affected by both selection
and information bias, and only one used multivariate anal-
ysis to correct for co-existing diseases or case-mix. The term
CTIA was accurately defined by the authors in only 11 out of
the 34 papers.6,8,17e19,22,24,28,30,31,38 Table 2 summarises
these definitions across the 12 CTIA series. Only three
studies provided details regarding the actual number of TIAs
or the time period needed for a cluster of TIAs to be defined
as CTIA. Nehler et al.18 defined CTIA as ‘‘>2 TIAs/24 hours,’’
Brandl et al.30 as ‘‘at least one TIA a day’’ and Karkos et al.38
as ‘‘3 or more TIAs within the preceding 7 days.’’
There were 84 (68%) men and 39 (32%) women with
a mean age (range) of 64 (40e87) years. Majority of the
patients (90%) had significant internal carotid artery (ICA)
stenosis; intra-operatively, 12 (8%) were found to have
complete occlusion, whereas in two patients, CTIAs were
due to recurrent embolisation from a carotid artery aneu-
rysm.29 Few studies reported information regarding the
timing of surgery after the diagnosis of CTIAs. Some
surgeons would perform emergency CEA, usually within 12e
24 h,19,29,30 Others, such as the Leicester and the Portland
groups, preferred to wait slightly longer in an attempt to
achieve neurological stabilisation and avoid emergency
surgery.18,38 The median delay to surgery was 3 days and 5
days, respectively, in these two studies. Carotid procedures
included 158 standard CEAs (91%) and seven bypasses to the
ICA (polytetrafluoroethylene (PTFE) in three patients and
reversed long saphenous vein in four). In one early study, all
eight patients presenting with CTIAs underwent extrac-
ranialeintracranial (ECeIC) bypass (superficial temporal to
middle cerebral artery anastomosis).6 An indwelling shunt
was used in 118 out of 134 (88%) patients on whom infor-
mation was available. In majority of the studies, additional
medical treatment included systemic heparinisation;
whereas two patients in the Leicester series were given
clopidogrel instead.38 Finally, in a report from Japan, one
patient received pre-treatment with free-radicalscavenger, such as edaravone.37 Overall, the pooled peri-
operative stroke, combined stroke/death and combined
stroke/death/major cardiac event rate was 6.5% (95% CI:
3.4e10.4), 9.0% (95% CI: 4.3e15.1) and 10.9% (95% CI: 5.5e
17.9), respectively (Figs. 1e3). There was no statistically
significant heterogeneity across the 12 series. Since most
studies were affected by selection bias, we still opted to
present data using the random effects model despite the
lack of statistically significant heterogeneity.
SIE (group II)
A total of 16 studies were identified, with data on 114
patients being operated upon for SIE (Table
2).6,7,9,12,14,15,19,21,23e25,27,30,31,35,38 Basic information
presents is presented in Table 3. All but two6,24 studies
were retrospective. Similar to group I, the majority of SIE
studies were of low methodological quality suffering from
both selection and information bias. Only two studies used
multivariate analysis. According to the gender information
available, 62 were male, and the mean age (range) of all
the patients was 66 (42e85) years. Majority of the patients
underwent endarterectomy (97%), and a shunt was used in
55 (68%) cases with available information. The peri-opera-
tive stroke, combined stroke/death and combined stroke/
death/major cardiac event rate was 16.9% (95% CI: 9.2e
26.2), 20.0% (95% CI: 12.5e28.6) and 20.8% (95% CI: 13.2e
29.6), respectively (Figs. 4e6). There was no statistically
significant heterogeneity across the 16 series. Given that
most studies were affected by selection bias, we opted to
present the pooled data using the random effects model
despite the lack of statistically significant heterogeneity.
The initial evolving neurological deficit deteriorated in 7%,
remained the same in 7% and improved in the majority
(86%) of the patients.
Discussion
Surgery in the neurologically unstable patient had been
considered as highly risky in the past, the rates of peri-
operative mortality and of persistent or worsened neuro-
logical status being as high as 10-fold worse than those
anticipated after elective carotid surgery.13,25 Tradition-
ally, surgeons have been reluctant to operate on such
unstable patients because of the fear of transforming an
ischaemic stroke into a haemorrhagic one.8 However, this is
no longer so rigidly adhered to and may change in the
future as trials examine the combined role of surgery or
endovascular intervention and thrombolysis in this situa-
tion. The easier access to diagnostic modalities, such as
colour duplex scanning, transcranial Doppler, intra-arterial
digital subtraction carotid angiography and magnetic reso-
nance or computed tomography angiography, the organi-
sation of the admission wards into acute stroke units
staffed by experienced personnel, and, finally, a closer co-
operation between vascular surgeons, neurologists and
stroke physicians have facilitated identification of neuro-
logically unstable patients who may benefit from urgent
carotid surgery.33 Furthermore, several more recent series
demonstrate that urgent carotid surgery could be worth-
while for selected patients.17e21,29e31
Table 1 Series (in chronological order) of patients undergoing surgery for CTIAs
First author
and year
Study quality Pts
(M/F)
Mean age
(range)
Carotid
stenosis/
occlusion
Median
delay
to surgery
Additional
medical
therapy
Technique Shunt Stroke Stroke
and
mortality
Stroke,
mortality
and major
cardiac
events
P/R Selection
bias
Information
bias
Multivariate
analysis
Diaz6 1985 P Unclear Yes No 8 (4/4) 58 (40e72) 4/4 NA NA ECeIC
bypass
NA 1 (12%) 1 (12%) 1 (12%)
Ricotta7 1985 R Unclear Yes No 3 (NA) NA NA NA NA CEA NA 0 0 0
Wilson17 1993 P Yes Unclear No 12 (NA) 61 (42e69) 12/0 NA Heparin CEA 12 0 0 0
Nehler18 1993 P No Yes No 29 (26/3) 63 (51e83) 29/0 5 days Heparin 24 CEA,
5 BP
24 1 (3%) 2 (6%) 4 (13%)
Greenhalgh19 1993 R Yes Yes No 7 (5/2) 62 (55e72) 6/1 ‘‘Emergency
CEA’’
NA CEA 7 1 (14%) 1 (14%) 1 (14%)
Golledge24 1996 P No No Yes 26 (6/20) 65 (38e82) NA NA NA CEA 19 4 (15%) 7 (27%) 7 (27%)
Schneider26 1999 R Yes Yes No 31 (NA) NA 31/0 NA Heparin Most CEA NA 0 0 0
Paterson29 2000 R Yes Yes No 2 (2/0) 66 (63e69) 2
aneurysms
1 day Heparin BP
(PTFE)
No 0 0 0
Brandl30 2001 R Unclear No No 7 (6/1) 69 (60e84) 7/0 1 day Heparin CEA 7 1 (14%) 1 (14%) 1 (14%)
Kasper31 2001 R Yes Yes No 7 (NA) NA 0/7 NA NA CEA 7 0 0 0
Kobayashi37 2007 R Yes Yes No 1 (1/0) 68 1/0 3 days Argatroban
and
edaravone
CEA No 0 0 0
Karkos38 2007 R Yes No No 43 (34/9) 66 (48e87) 43/0 3 days Heparin in
41;
clopidogrel
in 2
40 CEA,
3 BP
(vein)
41/43 2 (5%) 3 (7%) 6 (14%)
Total 176
(84/39)
64 (40e87) 132/12/2
aneurysms
158 CEA
(91%)
118/134
(71%)
10
(6%)
12
(7%)
20
(11%)
Study quality was assessed based on whether this was prospective or retrospective, whether there was suspicion of selection bias (yes/no/unclear) or information bias (yes/no/unclear)
and whether multivariate analysis had been employed. P: prospective; R: retrospective; NA: information not available; Pts: patients; M: male; F: female; ECeIC bypass: extracraniale
intracranial bypass; CEA: carotid endarterectomy; BP: bypass; PTFE: polytetrafluoroethylene.
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Surgery for CTIAs [random effects]
0,0 0,2 0,4 0,6 0,8 1,0
combined 0,090 (0,043, 0,151)
Karkos 0,070 (0,015, 0,191)
Kobayashi 0,000 (0,000, 0,975)
Kasper 0,000 (0,000, 0,410)
Brandl 0,143 (0,004, 0,579)
Paterson 0,000 (0,000, 0,842)
Schneider 0,000 (0,000, 0,112)
Golledge 0,269 (0,116, 0,478)
Greenhalgh 0,143 (0,004, 0,579)
Nehler 0,069 (0,008, 0,228)
Wilson 0,000 (0,000, 0,265)
Ricotta 0,000 (0,000, 0,708)
Diaz 0,125 (0,003, 0,527)
Stroke/death rates (95% confidence
interval)
Figure 2 Forest plot for stroke/death rates after surgery for
CTIAs. The pooled stroke/death rate was 9.0% (95% CI:
4.3e15.1). Cochran Q-statisticZ 16.4 (dfZ 11), PZ 0.12.
Surgery for CTIAs [random effects]
Table 2 Definition of CTIA across the 12 studies
Author Definition of CTIA
Diaz6 TIAs which were increasing in frequency,
severity and duration in the preceding day
Ricotta7 NA
Wilson17 Recurrent, transient, cerebral or retinal
ischaemia in the distribution of the carotid
artery, characterised by definite worsening
in symptom pattern whether in terms of
event frequency, duration or severity
Nehler18 Ocular or cerebral hemispheric events of
increasing frequency (>2 events/24 h) and/
or severity (subsequent events of longer
duration or greater neurologic deficit than
prior events) and lasting <24 h with return
to neurologic baseline between events
Greenhalgh19 A succession of TIAs in which succeeding
TIAs are more severe or more frequent
Golledge24 A succession of TIAs in which succeeding
TIAs are more severe or frequent
Schneider26 NA
Paterson29 NA
Brandl30 TIAs increasing in severity or frequency to at
least once a day
Kasper31 Multiple similar ipsilateral hemispheric
neurologic events with the deficit
continuing to resolve within 24 h
Kobayashi37 NA
Karkos38 Three or more TIAs within the preceding 7
days
Urgent Carotid Surgery in Patients with CTIAs and SIE 283Reconstruction of the ICA has been offered for several
‘urgent’ indications, such as recurrent or CTIAs, acute or
recurrent stroke, SIE and recent total ICA occlusion. This
study is aimed to review the literature specifically on the
surgical management of CTIAs and SIE. However, one of the
problems preventing a satisfactory meta-analysis of pub-
lished studies is that the authors usually group all these
‘urgent’ indications together, or mix these with proceduresSurgery for CTIAs [random effects]
0,0 0,2 0,4 0,6 0,8 1,0
combined 0,0644 (0,0339, 0,1038)
Karkos 0,0465 (0,0057, 0,1581)
Kobayashi 0,0000 (0,0000, 0,9750)
Kasper 0,0000 (0,0000, 0,4096)
Brandl 0,1429 (0,0036, 0,5787)
Paterson 0,0000 (0,0000, 0,8419)
Schneider 0,0000 (0,0000, 0,1122)
Golledge 0,1538 (0,0436, 0,3487)
Greenhalgh 0,1429 (0,0036, 0,5787)
Nehler 0,0345 (0,0009, 0,1776)
Wilson 0,0000 (0,0000, 0,2646)
Ricotta 0,0000 (0,0000, 0,7076)
Diaz 0,1250 (0,0032, 0,5265)
Stroke rates (95% confidence interval)
Figure 1 Forest plot for stroke rates after surgery for CTIAs.
The pooled stroke rate was 6.5% (95% CI: 3.4e10.4). Cochran
Q-statisticZ 10.9 (dfZ 11), PZ 0.45.on stable symptomatic or even asymptomatic patients.5e38
In addition, these series report on a small number of
patients over a long period of time. Therefore, accurate
data on a large contemporary number of patients under-
going surgery for CTIAs and SIE are lacking. Another limi-
tation of the study is that there is no uniform definition for
CTIAs. Although it is widely accepted that these represent
disabling, recurrent transient cerebral or retinal ischaemia
characterised by an increased frequency, duration or
severity of events,17 there is no consensus on the number of
TIAs or time period needed in order to define an unstable
neurological state as ‘crescendo’ TIA symptomatology. The
Charing Cross Group reject the term ‘CTIA’, because this
implies that the deficit is temporary, whereas at the time of
surgery it is unknown whether the patient is going to
progress or to improve again from this deficit.8 In their
series of patients with actively neurological deficits,0,0 0,2 0,4 0,6 0,8 1,0
combined 0,109 (0,055, 0,179)
Karkos 0,140 (0,053, 0,279)
Kobayashi 0,000 (0,000, 0,975)
Kasper 0,000 (0,000, 0,410)
Brandl 0,143 (0,004, 0,579)
Paterson 0,000 (0,000, 0,842)
Schneider 0,000 (0,000, 0,112)
Golledge 0,269 (0,116, 0,478)
Greenhalgh 0,143 (0,004, 0,579)
Nehler 0,138 (0,039, 0,317)
Wilson 0,000 (0,000, 0,265)
Ricotta 0,000 (0,000, 0,708)
Diaz 0,125 (0,003, 0,527)
Combined stroke, death and major
cardiac event rates (95% confidence interval)
Figure 3 Forest plot for the combined stroke, death and
major cardiac event rates after surgery for CTIAs. The pooled
rate was 10.9% (95% CI: 5.5e17.9). Cochran Q-statisticZ 17.9
(dfZ 11), PZ 0.08.
Table 3 Series (in chronological order) of patients undergoing surgery for SIE
First author
and year
Study quality Pts (M/F) Mean age
(range)
Carotid
stenosis/
occlusion
Technique Shunt roke Stroke and
mortality
Stroke,
mortality
and major
cardiac
events
Worsen/
equal/
better
P/R Selection
bias
Information
bias
Multivariate
analysis
Diaz6 1985 P Unclear Yes No 3 (1/2) 59 (45e72) 3/0 3 ECeIC
bypass
No 0 0 0/0/3
Ricotta7 1985 R Unclear Yes No 6 (NA) NA NA CEA NA 0 0 0/0/6
Meyer9 1986 R Unclear Yes No 3 (NA) NA 0/3 CEA All 0 0 0/1/2
Friedman12 1988 R Unclear Yes No 7 (NA) NA NA CEA All (57%) 4 (57%) 4 (57%) NA
Brook14 1990 R Yes Yes Yes 4 (NA) NA NA CEA NA (50%) 2 (50%) 2 (50%) NA
McCormick15 1992 R Yes Yes No 4 (NA) NA 0/4 CEA No (25%) 1 (25%) 1 (25%) 1/0/3
Greenhalgh19 1993 R Yes Yes No 15 (7/8) 65 (46e80) 14/0/1
aneurysm
CEA 7 (6%) 1 (6%) 1 (6%) 1/0/14
Goldstein21 1994 R Yes Yes No 5 (NA) NA NA NA NA (20%) 1 (20%) 1 (20%) NA
Mattos23 1995 R Yes Yes No 9 (NA) NA NA CEA NA (55%) 5 (55%) 5 (55%) NA
Golledge24 1996 P No No Yes 25 (12/13) 67 (50e80) NA CEA 12 (8%) 3 (12%) 3 (12%) NA
McKinsey25 1996 R Unclear Yes No 5 (NA) NA NA CEA All 1 (20%) 1 (20%) NA
Tretter27 1999 R Unclear Yes Yes 7 (NA) NA NA CEA NA (14%) 1 (14%) 1 (14%) 1/0/6
Brandl30 2001 R Unclear No No 9 (6/3) 69 (42e79) 7/2 CEA All (11%) 1 (11%) 1 (11%) 1/0/8
Kasper31 2001 R Yes Yes No 2 (NA) NA 0/2 CEA All 0 0 NA
Van der Mieren35
2005
R Yes Yes No 2 (2/0) 61 (55e67) 0/2 CEA All 0 0 0/0/2
Karkos38 2007 R Yes No No 8 (6/2) 72 (61e85) 7/1 CEA All 1 (12.5%) 2 (25%) 0/3/4
Total 114
(34/28)
66
(42e85)
31/14/1
aneurysm
106 CEA
(97%)
55/81
(68%) 6%)
21
(18%)
22
(19%)
4/4/48
(7%/7%/86%)
Study quality was assessed by whether this was prospective (P) or retrospective (R), whether there was suspicion of selection bias (y no/unclear) or information bias (yes/no/unclear)
and whether multivariate analysis had been used. The last column summarises the patients’ postoperative status with regard to the p perative neurological deficit, that is, worse, equal
or better. NA: information not available; Pts: patients; M: male; F: female; ECeIC bypass: extracranialeintracranial bypass; CEA: c tid endarterectomy.
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Surgery for SIE [random effects]
0,0 0,2 0,4 0,6 0,8 1,0
combined 0,169 (0,092, 0,262)
Karkos 0,000 (0,000, 0,369)
Van der Mieren 0,000 (0,000, 0,842)
Kasper 0,000 (0,000, 0,842)
Brandl 0,111 (0,003, 0,482)
Tretter 0,143 (0,004, 0,579)
McKinsey 0,000 (0,000, 0,522)
Golledge 0,080 (0,010, 0,260)
Mattos 0,556 (0,212, 0,863)
Goldstein 0,200 (0,005, 0,716)
Greenhalgh 0,067 (0,002, 0,319)
McCormick 0,250 (0,006, 0,806)
Brook 0,500 (0,068, 0,932)
Friedman 0,571 (0,184, 0,901)
Meyer 0,000 (0,000, 0,708)
Ricotta 0,000 (0,000, 0,459)
Diaz 0,000 (0,000, 0,708)
Stroke rates (95% confidence interval)
Figure 4 Forest plot for stroke rates after surgery for SIE.
The pooled stroke rate was 16.9% (95% CI: 9.2e26.2). Cochran
Q-statisticZ 24.0 (dfZ 15), PZ 0.06.
Surgery for SIE [random effects]
0,0 0,2 0,4 0,6 0,8 1,0
combined 0,208 (0,132, 0,296)
Karkos 0,250 (0,032, 0,651)
Van der Mieren 0,000 (0,000, 0,842)
Kasper 0,000 (0,000, 0,842)
Brandl 0,111 (0,003, 0,482)
Tretter 0,143 (0,004, 0,579)
McKinsey 0,200 (0,005, 0,716)
Golledge 0,120 (0,025, 0,312)
Mattos 0,556 (0,212, 0,863)
Goldstein 0,200 (0,005, 0,716)
Greenhalgh 0,067 (0,002, 0,319)
McCormick 0,250 (0,006, 0,806)
Brook 0,500 (0,068, 0,932)
Friedman 0,571 (0,184, 0,901)
Meyer 0,000 (0,000, 0,708)
Ricotta 0,000 (0,000, 0,459)
Diaz 0,000 (0,000, 0,708)
Stroke/death/major cardiac event
rates (95% confidence interval)
Figure 6 Forest plot for stroke/death/major cardiac event
rates after surgery for SIE. The pooled rate was 20.8% (95% CI:
13.2 to 29.6). Cochran Q-statisticZ 19.55 (dfZ 15) PZ 0.19.
Urgent Carotid Surgery in Patients with CTIAs and SIE 285surgical intervention occurred during an attack, and,
therefore, the outcome without surgery was unknown.
Although the natural history of CTIAs has not been evalu-
ated prospectively in large series, medical treatment shows
a poor prognosis with a significant number of patients
suffering a stroke within a short interval.24
This study has shown that the pooled stroke and stroke/
death rates after carotid surgery for CTIAs in 176 patients
over the last 23 years were 6.5% and 9.0%, respectively. As
expected, the risks of urgent CEA for ‘crescendo’ symptoms
are higher than that of an elective procedure for stable
symptoms. This was confirmed by a recent systematic
review studying the risk of CEA in relation to the clinical
indication for and timing of surgery.43 This meta-analysis
from Oxford showed that CEA for CTIAs had a much higher
risk than elective CEA for single episodes of TIA (odds ratio,Surgery for SIE [random effects]
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Figure 5 Forest plot for stroke/death rates after surgery for
SIE. The pooled stroke/death rate was 20.0% (95% CI: 12.5 to
28.6). Cochran Q-statisticZ 19.32 (dfZ 15), PZ 0.20.ORZ 7.5; 95% CI: 3.7 to >10; p< 0.001). Nevertheless, this
was based on the results of only two series.13,24
Fluctuating neurological deficits or SIE may be the initial
presenting pattern in 15e30% of the cases caused by
extracranial carotid artery disease.26,39 Despite the
unpredictable course of stroke in the individual patient, the
natural history in this group is unfavourable, with mortality
rates of 14e18% and disability rates of 31e71%.24,40,43
Patients with mild-to-moderate progressive deficit may
have a recovery rate/minor stroke of 88% and those with
severe deficit 57.5%.24 The risks of CEA for SIE in the present
review were significant; the overall stroke and stroke/death
rates in 114 patients being 16.9% and 20.0%, respectively.
Comparing the risks of urgent CEA for SIE to those after
delayed elective CEA for stable stroke, the Oxford meta-
analysis, enrolling eight series10,12,14,20,21,24,27,44 published
between 1983 and 1999, confirmed a much higher operative
risk for the former group (ORZ 3.2; 95% CI: 1.9e5.6;
p< 0.001).43
Combined reporting and mixing of different ‘urgent’
subgroups in the literature was a problem which we could
not overcome during the design of this systematic review.
As a result, we opted not to include the studies from
which accurate data extraction on the CTIA and SIE
subgroups was not possible. Unfortunately, excluding
these series from the larger pool of 915 patients (only 12%
of whom had been operated upon for ‘urgent’ indications
other than CTIAs and SIE) left a much smaller number of
patients for analysis. The Oxford Group also analysed 13
studies10,12e14,20,21,23,24,26,27,35,39 reporting data on these
‘urgent’ groups, and although the number of cases in each
individual study was small, the results were consistent with
a trend towards a higher operative risk in the urgent
cases.43 The combined relative odds of operative stroke and
death resulting from surgery for these ‘urgent’ indications
versus non-urgent surgery for stable, equivalent, symp-
tomatic indications was 4.9 (95% CI: 3.4e7.1; p< 0.001).
When major cardiac events were taken also into
account, the combined stroke/death/major cardiac event
286 C.D. Karkos et al.rate in the pooled data was even higher. Reviewing our own
experience of treating patients with CTIAs and SIE
confirmed our impression that, in addition to a higher
likelihood of mortality and neurological complications, such
patients are at higher risk for cardiac events. The average
myocardial infarction and major cardiac complication rates
after elective CEA are reported to be around 1.0%45 and
2.4%,46 respectively. This contrasts with the 14% major
cardiac event rate encountered in our own series of 51
patients.38 Across the pooled series, cardiac morbidity
produced a combined stroke/death/major cardiac event
rate of 10.9% and 20.8% in groups I and II, respectively. In
fact, the true figures may be even higher given that cardiac
complications were not uniformly reported in the 21 arti-
cles. Majority of the studies were retrospective and not
designed to record cardiac morbidity. Some report only on
myocardial infarctions, others on all types of cardiac
complications and many do not differentiate between fatal
and non-fatal cardiac complications. Finally, no study has
used routine serial electrocardiograms and cardiac enzymes
to document the frequency of peri-operative cardiac
events, a policy known to produce much more accurate
recording of ischaemic cardiac complications.45
The relatively higher incidence of peri-operative cardiac
complications after urgent CEA when compared to elective
surgery should not be surprising, as a similar trend is seen
after other urgent arterial procedures, such as aorto-iliac
and infra-inguinal surgery.45 The reasons for this are
unclear, but are thought to be due to the fact that these
patients have not had a full preoperative assessment with
correction of appropriate preoperative medical risk factors.
Nevertheless, in the neurologically unstable patient, the
higher likelihood of cardiac complications may also point
towards a common systemic cause for atherosclerotic pla-
que disruption in both the carotid and coronary vascular
beds. Rothwell et al. have shown an association between
plaque irregularities in the carotid arteries and plaque
instability and rupture in the coronary arteries, that is,
indirect evidence that some individuals have a systemic
predisposition to irregularity and rupture of atherosclerotic
plaques.47 Of course, one might argue that increased
cardiac morbidity may simply reflect selection bias and the
fact that these patients have significant pre-existing coro-
nary artery disease. An alternative explanation could be
the low use of peri-operative beta-blockade and statins.
Naturally, these reports span in excess of two decades, and
many patients had been treated before the car-
dioprotective effect of peri-operative beta-blockers and
the anti-inflammatory properties of statins were well
documented.48,49
This systematic review aims to document the results of
urgent carotid surgery for CTIAs and SIE over the last two
decades. The results suggest a higher operative risk than in
the elective setting; the quoted figures, however, should be
interpreted with caution because these are historical series
with small numbers and selection bias. Many advances have
occurred over the last few years and our understanding of
these acutely symptomatic patients has improved based on
new diagnostic techniques and close clinical observation
during care in the stroke unit. Diffusion-weighted magnetic
resonance imaging (MRI) would not only identify early
stroke, but there is also evidence that TIA and stroke can bedifferentiated by analysing early signal-intensity changes.50
On the other hand, patient admission directly into organ-
ised stroke units or even a referral to a TIA clinic with
round-the-clock access (SOS-TIA) would allow immediate
initiation of preventive treatment and improve clinical
decision making and identification of candidates for urgent
carotid surgery.51,52 Furthermore, additional medical
therapy may prove to be an important adjunct to surgery.
Apart from systemic heparinisation, other therapeutic
options that may potentially reduce the thrombo-embolic
potential and/or exert a neuroprotective effect include the
use of anti-platelet agents, such as clopidogrel,38,53 the
transcranial Doppler-directed Dextran therapy34,54,55 and
the free-radical scavengers, such as edaravone.37,56 Finally,
thrombolysis and carotid stenting may also prove to be
important treatment modalities in the future management
of the neurologically unstable patient; however, their role
has yet to be defined.
In conclusion, the combined risk of neurological and
cardiac complications following urgent CEA for CTIAs or SIE
is higher than that expected after elective cases, but is still
acceptable, considering the natural history of patients with
unstable neurological symptoms. The increased likelihood
of cardiac events would suggest that a systemic trigger may
mediate acute atherosclerotic plaque disruption or may
reflect the large burden of coronary artery disease in this
population.
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